Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitorsRuifeng Wang, Maosheng Cheng, Bowen Yang et al.|European Journal of Medicinal Chemistry|2019Cited by 55
Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implicationsWei Liu, Aleksandra A. Pandyra, Paweł Stachura et al.|Journal of Experimental & Clinical Cancer Research|2020Cited by 51